Literature DB >> 16627060

Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired.

Jai Young Cho1, Kyung-Suk Suh, Choon Hyuck Kwon, Nam-Joon Yi, Kuhn Uk Lee.   

Abstract

BACKGROUND: An understanding of the regeneration power and operative risk of steatotic livers after hepatectomy is still unclear. We evaluated the volume regeneration and outcome of steatotic livers after donor hepatectomy.
METHODS: Fifty-four, consecutive living liver donors from September 2002 to December 2003 were evaluated prospectively by volumetric analysis, liver-spleen ratio, and liver attenuation index; the latter has been shown by serial computed tomographic scanning to be correlated strongly with histologic steatosis. Donors were followed up completely for at least 1 year (460-915 days) and were allocated according to histologic degree of macrovesicular steatosis: group 1, <5% (n = 36); group 2, 5%-30% (n = 18).
RESULTS: No mortality or hepatic failure was observed, and no donor required reoperation or intraoperative transfusion. The results of serial liver function tests, and major and minor morbidities were comparable between groups. Liver-spleen ratio and liver attenuation index remained at a constant level above normal values postoperatively in group 1, but increased rapidly above normal values in group 2. No difference in the rate of liver regeneration at 10 days after hepatectomy was found between the groups (P = .487), but the liver regeneration rate at 3 months after hepatectomy in group 1 was slightly higher than that in group 2 (P < .044). However, no difference was observed between the 2 groups at 1 year after hepatectomy (P = .4).
CONCLUSIONS: Mild hepatic steatosis is cleared immediately after hepatectomy, and early regeneration power is impaired, but the long-term regenerative power is comparable. Hepatectomy in donors with mild steatosis can be performed with low morbidity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16627060     DOI: 10.1016/j.surg.2005.09.007

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  18 in total

1.  Liver regeneration in donors evaluated by Tc-99m-GSA scintigraphy after living donor liver transplantation.

Authors:  Masaki Kaibori; Sang Kil Ha-Kawa; Yoichiro Uchida; Morihiko Ishizaki; Takamichi Saito; Kosuke Matsui; Junko Hirohara; Koichi Tanaka; Yasuo Kamiyama
Journal:  Dig Dis Sci       Date:  2007-08-04       Impact factor: 3.199

2.  Effect of branched-chain amino acid supplementation on functional liver regeneration in patients undergoing portal vein embolization and sequential hepatectomy: a randomized controlled trial.

Authors:  Toru Beppu; Hidetoshi Nitta; Hiromitsu Hayashi; Katsunori Imai; Hirohisa Okabe; Shigeki Nakagawa; Daisuke Hashimoto; Akira Chikamoto; Takatoshi Ishiko; Morikatsu Yoshida; Yasuyuki Yamashita; Hideo Baba
Journal:  J Gastroenterol       Date:  2015-04-08       Impact factor: 7.527

Review 3.  Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantation.

Authors:  Amit D Tevar; Calissia Clarke; Jiang Wang; Steven M Rudich; E Steve Woodle; Alex B Lentsch; Michael L Edwards
Journal:  J Am Coll Surg       Date:  2010-04       Impact factor: 6.113

4.  Outcomes of Simultaneous Major Liver Resection and Colorectal Surgery for Colorectal Liver Metastases.

Authors:  Paramin Muangkaew; Jai Young Cho; Ho-Seong Han; Yoo-Seok Yoon; YoungRok Choi; Jae Yool Jang; Hanlim Choi; Jae Seong Jang; Seong Uk Kwon
Journal:  J Gastrointest Surg       Date:  2015-10-15       Impact factor: 3.452

Review 5.  Liver transplantation and non-alcoholic fatty liver disease.

Authors:  Petros Zezos; Eberhard L Renner
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 6.  Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS).

Authors:  Nuh N Rahbari; O James Garden; Robert Padbury; Guy Maddern; Moritz Koch; Thomas J Hugh; Sheung Tat Fan; Yuji Nimura; Joan Figueras; Jean-Nicolas Vauthey; Myrddin Rees; Rene Adam; Ronald P Dematteo; Paul Greig; Val Usatoff; Simon Banting; Masato Nagino; Lorenzo Capussotti; Yukihiro Yokoyama; Mark Brooke-Smith; Michael Crawford; Christopher Christophi; Masatoshi Makuuchi; Markus W Büchler; Jürgen Weitz
Journal:  HPB (Oxford)       Date:  2011-06-07       Impact factor: 3.647

7.  Hepatocyte proliferation during liver regeneration is impaired in mice with methionine diet-induced hyperhomocysteinemia.

Authors:  Wei-Hua Liu; Yue-Shui Zhao; Shun-Yu Gao; Shu-De Li; Jun Cao; Ke-Qin Zhang; Cheng-Gang Zou
Journal:  Am J Pathol       Date:  2010-09-23       Impact factor: 4.307

Review 8.  Drug-induced steatohepatitis.

Authors:  Vaishali Patel; Arun J Sanyal
Journal:  Clin Liver Dis       Date:  2013-09-04       Impact factor: 6.126

9.  Influence of Kupffer cells and platelets on ischemia-reperfusion injury in mild steatotic liver.

Authors:  Koichi Ogawa; Tadashi Kondo; Takafumi Tamura; Hideki Matsumura; Kiyoshi Fukunaga; Tatsuya Oda; Nobuhiro Ohkohchi
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

10.  Donor Hepatic Steatosis Induce Exacerbated Ischemia-Reperfusion Injury Through Activation of Innate Immune Response Molecular Pathways.

Authors:  Ricardo C Gehrau; Valeria R Mas; Catherine I Dumur; Jihee L Suh; Ashish K Sharma; Helen P Cathro; Daniel G Maluf
Journal:  Transplantation       Date:  2015-12       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.